Literature DB >> 1205617

Multiple sclerosis-associated agent: transmission to animals and some properties of the agent.

U Koldovsky, P Koldovsky, G Henle, W Henle, R Ackermann, G Haase.   

Abstract

In confirmation and extension of observations by Carp and his associates, brain tissue and sera from patients with multiple sclerosis (MS) were found to harbor an agent which induces a transitory depression in polymorphonuclear leukocytes (PMN) in mice as well as in rats, hamsters, and guinea pigs. All of eight MD brains contained this agent at titers as high as 10(-9)/g of brain tissue. The agent was found in MS sera at titers up to 10(-3)/ml of serum, but its presence depended to some extent on the clinical status of the patients; it was observed more frequently in sera of patients with active disease (73%) thatn in sera of patients with quiescent disease (31%). Control brain tissues or sera failed to induce PMN depression. The apparently MS-associated agent (MSAA) passed through 50-nm but not 25-nm membrane filters (Millipore Corp.) and was largely sedimented at 105,000 X g but not at 50,000 X g for 1 h. It multiplied to high titers in the central nervous tissue of the inoculated animals and could be serially transmitted from animal to animal by passage of brain homeganates. Various observations and considerations appear to preclude that MS-associated agent represents an indigenous animal virus. Although its role in MS remains to be determined, it should be considered a candidate for the etiology of this disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1205617      PMCID: PMC415443          DOI: 10.1128/iai.12.6.1355-1366.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  Comparison of normal blood picture of young adults from 18 inbred strains of mice.

Authors:  E S RUSSELL; E F NEUFELD; C T HIGGINS
Journal:  Proc Soc Exp Biol Med       Date:  1951-12

Review 2.  Virologic studies of multiple sclerosis and other chronic and relapsing neurological diseases.

Authors:  R T Johnson; R M Herndon
Journal:  Prog Med Virol       Date:  1974

3.  Multiple sclerosis-associated agent: neutralization of the agent by human sera.

Authors:  G Henle; U Koldovsky; P Koldovsky; W Henle; R Ackermann; G Haase
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

4.  No mouse PMN leukocyte depression after inoculation with brain tissue from multiple sclerosis or spongiform encephalopathies.

Authors:  P Brown; D C Gajdusek
Journal:  Nature       Date:  1974-01-25       Impact factor: 49.962

5.  Decreased percentage of polymorphonuclear neutrophils in mouse peripheral blood after inoculation with material from multiple sclerosis patients.

Authors:  R I Carp; P C Licursi; P A Merz; G S Merz
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

  5 in total
  9 in total

1.  Editorial: Multiple sclerosis.

Authors: 
Journal:  Br Med J       Date:  1976-05-01

2.  Multiple sclerosis: recent advances in diagnosis clinical immunology and virology.

Authors:  D W Paty
Journal:  Can Med Assoc J       Date:  1977-07-23       Impact factor: 8.262

3.  A 'profile' of immune responsiveness in multiple sclerosis.

Authors:  G R Symington; I R Mackay; S Whittingham; J White; J D Buckley
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

Review 4.  Measles virus and its associated diseases.

Authors:  E M Morgan; F Rapp
Journal:  Bacteriol Rev       Date:  1977-09

5.  Multiple sclerosis in Coloured South Africans.

Authors:  F R Ames; S Louw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-08       Impact factor: 10.154

6.  Multiple sclerosis-associated agent: neutralization of the agent by human sera.

Authors:  G Henle; U Koldovsky; P Koldovsky; W Henle; R Ackermann; G Haase
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

7.  Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections.

Authors:  D C Poskanzer; J L Sever; J L Sheridan; L B Prenney
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

8.  The enhancing effect of multiple sclerosis brain homogenates on the active E rosette forming lymphocytes.

Authors:  H Offner; S C Rastogi; G Konat; J Calusen
Journal:  J Neurol       Date:  1978-08-25       Impact factor: 4.849

Review 9.  Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis.

Authors:  Bert A 't Hart
Journal:  Primate Biol       Date:  2019-05-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.